FDA asks maker of opioid painkiller opana ER to pull drug from market
(HealthDay)—Sales of reformulated Opana ER, a prescription opioid painkiller, should be halted in the United States, the U.S. Food and Drug Administration says.
Jun 9, 2017
1
1